164 related articles for article (PubMed ID: 20607226)
1. The live-attenuated yellow fever vaccine 17D induces broad and potent T cell responses against several viral proteins in Indian rhesus macaques--implications for recombinant vaccine design.
Mudd PA; Piaskowski SM; Neves PC; Rudersdorf R; Kolar HL; Eernisse CM; Weisgrau KL; de Santana MG; Wilson NA; Bonaldo MC; Galler R; Rakasz EG; Watkins DI
Immunogenetics; 2010 Sep; 62(9):593-600. PubMed ID: 20607226
[TBL] [Abstract][Full Text] [Related]
2. Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E.
Co MD; Terajima M; Cruz J; Ennis FA; Rothman AL
Virology; 2002 Feb; 293(1):151-63. PubMed ID: 11853408
[TBL] [Abstract][Full Text] [Related]
3. Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice.
Ma J; Boudewijns R; Sanchez-Felipe L; Mishra N; Vercruysse T; Buh Kum D; Thibaut HJ; Neyts J; Dallmeier K
Emerg Microbes Infect; 2021 Dec; 10(1):2279-2290. PubMed ID: 34792431
[TBL] [Abstract][Full Text] [Related]
4. The yellow fever 17D virus as a platform for new live attenuated vaccines.
Bonaldo MC; Sequeira PC; Galler R
Hum Vaccin Immunother; 2014; 10(5):1256-65. PubMed ID: 24553128
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques.
Martins MA; Bonaldo MC; Rudersdorf RA; Piaskowski SM; Rakasz EG; Weisgrau KL; Furlott JR; Eernisse CM; Veloso de Santana MG; Hidalgo B; Friedrich TC; Chiuchiolo MJ; Parks CL; Wilson NA; Allison DB; Galler R; Watkins DI
PLoS One; 2013; 8(1):e54434. PubMed ID: 23336000
[TBL] [Abstract][Full Text] [Related]
6. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
[TBL] [Abstract][Full Text] [Related]
7. Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes.
Barba-Spaeth G; Longman RS; Albert ML; Rice CM
J Exp Med; 2005 Nov; 202(9):1179-84. PubMed ID: 16260489
[TBL] [Abstract][Full Text] [Related]
8. Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins.
James EA; LaFond RE; Gates TJ; Mai DT; Malhotra U; Kwok WW
J Virol; 2013 Dec; 87(23):12794-804. PubMed ID: 24049183
[TBL] [Abstract][Full Text] [Related]
9. Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaques.
Bonaldo MC; Martins MA; Rudersdorf R; Mudd PA; Sacha JB; Piaskowski SM; Costa Neves PC; Veloso de Santana MG; Vojnov L; Capuano S; Rakasz EG; Wilson NA; Fulkerson J; Sadoff JC; Watkins DI; Galler R
J Virol; 2010 Apr; 84(7):3699-706. PubMed ID: 20089645
[TBL] [Abstract][Full Text] [Related]
10. YF17D-based vaccines - standing on the shoulders of a giant.
Sanchez-Felipe L; Alpizar YA; Ma J; Coelmont L; Dallmeier K
Eur J Immunol; 2024 May; 54(5):e2250133. PubMed ID: 38571392
[TBL] [Abstract][Full Text] [Related]
11. The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.
Akondy RS; Monson ND; Miller JD; Edupuganti S; Teuwen D; Wu H; Quyyumi F; Garg S; Altman JD; Del Rio C; Keyserling HL; Ploss A; Rice CM; Orenstein WA; Mulligan MJ; Ahmed R
J Immunol; 2009 Dec; 183(12):7919-30. PubMed ID: 19933869
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice.
Bassi MR; Larsen MA; Kongsgaard M; Rasmussen M; Buus S; Stryhn A; Thomsen AR; Christensen JP
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004464. PubMed ID: 26886513
[TBL] [Abstract][Full Text] [Related]
13. Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.
Jiang X; Dalebout TJ; Lukashevich IS; Bredenbeek PJ; Franco D
J Gen Virol; 2015 Apr; 96(Pt 4):804-814. PubMed ID: 25516543
[TBL] [Abstract][Full Text] [Related]
14. A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.
Mishra N; Boudewijns R; Schmid MA; Marques RE; Sharma S; Neyts J; Dallmeier K
mBio; 2020 Apr; 11(2):. PubMed ID: 32265332
[TBL] [Abstract][Full Text] [Related]
15. Protein structure shapes immunodominance in the CD4 T cell response to yellow fever vaccination.
Koblischke M; Mackroth MS; Schwaiger J; Fae I; Fischer G; Stiasny K; Heinz FX; Aberle JH
Sci Rep; 2017 Aug; 7(1):8907. PubMed ID: 28827760
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of Live-Attenuated Yellow Fever 17D Vaccine Virus Is Localized to a High-Fidelity Replication Complex.
Davis EH; Beck AS; Strother AE; Thompson JK; Widen SG; Higgs S; Wood TG; Barrett ADT
mBio; 2019 Oct; 10(5):. PubMed ID: 31641088
[TBL] [Abstract][Full Text] [Related]
17. Japanese encephalitis virus/yellow fever virus chimera is safe and confers full protection against yellow fever virus in intracerebrally challenged mice.
Yang H; Yang H; Li Z; Liu L; Wang W; He T; Fan F; Sun Y; Liu J; Li Y; Zeng X
Vaccine; 2018 Apr; 36(18):2450-2455. PubMed ID: 29580643
[TBL] [Abstract][Full Text] [Related]
18. Identification of three H-2K(d) restricted CTL epitopes of NS4A and NS4B protein from Yellow fever 17D vaccine.
Zhang W; Li X; Lin Y; Tian D
J Virol Methods; 2013 Feb; 187(2):304-13. PubMed ID: 23123122
[TBL] [Abstract][Full Text] [Related]
19. Immune activation alters cellular and humoral responses to yellow fever 17D vaccine.
Muyanja E; Ssemaganda A; Ngauv P; Cubas R; Perrin H; Srinivasan D; Canderan G; Lawson B; Kopycinski J; Graham AS; Rowe DK; Smith MJ; Isern S; Michael S; Silvestri G; Vanderford TH; Castro E; Pantaleo G; Singer J; Gillmour J; Kiwanuka N; Nanvubya A; Schmidt C; Birungi J; Cox J; Haddad EK; Kaleebu P; Fast P; Sekaly RP; Trautmann L; Gaucher D
J Clin Invest; 2014 Jul; 124(7):3147-58. PubMed ID: 24911151
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of the CD8 T-cell response following yellow fever virus 17D immunization.
Co MD; Kilpatrick ED; Rothman AL
Immunology; 2009 Sep; 128(1 Suppl):e718-27. PubMed ID: 19740333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]